ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welle, I.
Right arrow Articles by Gulsvik, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welle, I.
Right arrow Articles by Gulsvik, A.
Eur Respir J 2001; 17:1105-1111
Copyright ©ERS Journals Ltd 2001


Increased circulating levels of {alpha}1-antitrypsin and calprotectin are associated with reduced gas diffusion in the lungs

I. Welle1, P.S. Bakke1, G.E. Eide2, M.K. Fagerhol3, E. Omenaas2 and A. Gulsvik1

1 Dept of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway, 2 Center for Clinical Research, Haukeland University Hospital and Section for Medical Statistics, University of Bergen, Bergen, Norway and 3 Dept of Immunology and Transfusion Medicine, Ullevaal University Hospital, Oslo, Norway

CORRESPONDENCE: I. Welle, Dept of Thoracic Medicine, Haukeland Hospital, University of Bergen, N-5021, Bergen, Norway. Fax: 47 55975149

Keywords: {alpha}1-antitrypsin, calprotectin, epidemiology, gas exchange in the lungs, inflammation, sex

Received: July 26, 2000
Accepted January 18, 2001

This study was supported by the Royal Norwegian Council for Scientific and Industrial Research, the Norwegian Research Council for Science and Humanities, and the Norwegian Asthma and Allergy Association.

The aim was to examine the relationship of serum inflammatory markers to the level of single-breath diffusing capacity of carbon monoxide (TL,CO).

A stratified sample (n=1,121) of a Norwegian general population aged 18–73 yrs was examined. The inflammatory markers measured were calprotectin, a prominent protein in the cytosol fraction of neutrophil granulocytes, and {alpha}1-antitrypsin ({alpha}1-AT), the major inhibitor of neutrophil elastase in the lower respiratory system. Both markers have increased circulating levels in the course of an acute inflammatory reaction.

Subjects with a TL,CO<80% of predicted value had a higher level of both {alpha}1-AT (p=0.003) and calprotectin (p<0.03) than those with a TL,CO>100%. In multiple linear regression analyses, {alpha}1-AT was still significantly associated with TL,CO after adjusting for sex, age, smoking habits, haemoglobin, carboxyhaemoglobin, forced expiratory volume in one second and alveolar volume. In a similar analysis, no significant overall association was found between calprotectin and TL,CO, but in a stratified analysis, calprotectin was significantly related to TL,CO in females. However, no significant sex interaction in the relationship between the inflammatory markers and TL,CO was found.

The findings suggest that increased levels of {alpha}1-antitrypsin and of calprotectin are risk factors for decreased diffusing capacity of carbon monoxide.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Dahl, J. Vestbo, P. Lange, S. E. Bojesen, A. Tybjaerg-Hansen, and B. G. Nordestgaard
C-reactive Protein As a Predictor of Prognosis in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 250 - 255.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
S Kony, M Zureik, F Driss, C Neukirch, B Leynaert, and F Neukirch
Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study
Thorax, October 1, 2004; 59(10): 892 - 896.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
H. Andreassen and J. Vestbo
Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective
Eur. Respir. J., November 2, 2003; 22(46_suppl): 2S - 4s.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
The pharmacoepidemiology of COPD: Recent advances and methodological discussion
Eur. Respir. J., September 1, 2003; 22(43_suppl): 1S - 44s.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the European Respiratory Society.